Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy

Environmental Health and Preventive Medicine

Volumn 19, Issue 6, 2014, Pages 452-458

  Matsuzaka, Yasunari ^a   Kishi, Soichiro ^a,c   Aoki, Yoshitsugu ^a,d   Komaki, Hirofumi ^b   Oya, Yasushi ^b   Takeda, Shin ichi ^a   Hashido, Kazuo ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Becker muscular dystrophy; Biomarker; Facioscapulohumeral muscular dystrophy; Limb girdle muscular dystrophy; microRNAs

Indexed keywords

CREATINE KINASE; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 16; MICRORNA 206; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN1 MICRORNA, HUMAN; MIRN133 MICRORNA, HUMAN; MIRN206 MICRORNA, HUMAN;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE MARKER; DISTAL MYOPATHY; DISTAL MYOPATHY WITH RIMMED VACUOLE; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; EXOSOME; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; HUMAN; HUMAN CELL; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE MUSCULAR DYSTROPHY 2B; MALE; MOUSE; MUSCLE INJURY; MUSCLE REGENERATION; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY 1; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; ANIMAL; BLOOD; CASE CONTROL STUDY; JAPAN; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; ANIMALS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMANS; JAPAN; MICE; MICRORNAS; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUSCULAR DYSTROPHY, DUCHENNE; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84919791314     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-014-0405-7     Document Type: Article

References (24)

1. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861–74.
2. Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA, et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A. 2007;104:17016–21.
3. Eisenberg I, Alexander MS, Kunkel LM. miRNAS in normal and diseased skeletal muscle. J Cell Mol Med. 2009;13:2–11.
4. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–9.
5. Yao B, Li S, Chan EK. Function of GW182 and GW bodies in siRNA and miRNA pathways. Adv Exp Med Biol. 2013;768:71–96.
6. Mercuri E, Muntoni F. Muscular dystrophies. Lancet. 2013;381:845–60.
7. Emery AE. The muscular dystrophies. Lancet. 2002;359:687–95.
8. Takeshima Y, Yagi M, Okizuka Y, Awano H, Zhang Z, Yamauchi Y, et al. Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center. J Hum Genet. 2010;55:379–88.
9. Tsukamoto H, Inui K, Fukushima H, Nishigaki T, Taniike M, Tanaka J, et al. Molecular study of Duchenne and Becker muscular dystrophies in Japanese. J Inherit Metab Dis. 1991;14:819–24.
10. Yamagata H, Miki T, Sakoda S, Yamanaka N, Davies J, Shelbourne P, et al. Detection of a premutation in Japanese myotonic dystrophy. Hum Mol Genet. 1994;3:819–20.
11. Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 2012;11:891–905.
12. Mitsuhashi S, Kang PB. Update on the genetics of limb girdle muscular dystrophy. Semin Pediatr Neurol. 2012;19:211–8.
13. van Deutekom JC, Wijmenga C, van Tienhoven EA, Gruter AM, Hewitt JE, Padberg GW, et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet. 1993;2:2037–42.
14. Ikeda-Sakai Y, Manabe Y, Fujii D, Kono S, Narai H, Omori N, et al. Novel mutations of the GNE gene in distal myopathy with rimmed vacuoles presenting with very slow progression. Case Rep Neurol. 2012;4:120–5.
15. Malm C, Sjödin TL, Sjöberg B, Lenkei R, Renström P, Lundberg IE, et al. Leukocytes, cytokines, growth factors and hormones in human skeletal muscle and blood after uphill or downhill running. J Physiol. 2004;556:983–1000.
16. Zatz M, Rapaport D, Vainzof M, Passos-Bueno MR, Bortolini ER, Pavanello Rde C, et al. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in duchenne (DMD) as compared with becker (BMD) muscular dystrophy. J Neurol Sci. 1991;102:190–6.
17. Cacchiarelli D, Legnini I, Martone J, Cazzella V, D’Amico A, Bertini E, et al. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med. 2011;3:258–65.
18. Mizuno H, Nakamura A, Aoki Y, Ito N, Kishi S, Yamamoto K, et al. Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS ONE. 2011;6:e18388.
19. Jia Y, Suzuki N, Yamamoto M, Gassmann M, Noguchi CT. Endogenous erythropoietin signaling facilitates skeletal muscle repair and recovery following pharmacologically induced damage. FASEB J. 2012;26:2847–58.
20. Couteaux R, Mira JC, d’Albis A. Regeneration of muscles after cardiotoxin injury I. Cytological aspects. Biol Cell. 1988;62:171–82.
21. Roberts TC, Godfrey C, McClorey G, Vader P, Briggs D, Gardiner C, et al. Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Nucleic Acid Res. 2013;41:9500–13.
22. Forterre A, Jalabert A, Chikh K, Pesenti S, Euthine V, Granjon A, et al. Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts during muscle cell differentiation. Cell Cycle. 2014;13:78–89.
23. Hudson MB, Woodworth-Hobbs ME, Zheng B, Rahnert JA, Blount MA, Gooch JL, et al. miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export. Am J Physiol Cell Physiol. 2014;306:C551–8.
24. Liu N, Williams AH, Maxeiner JM, Bezprozvannaya S, Shelton JM, Richardson JA, et al. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest. 2012;122:2054–65.